Doxorubicin hydrochloride - CAS 25316-40-9
Not Intended for Therapeutic Use. For research use only.
Category:
ADCs
Product Name:
Doxorubicin hydrochloride
Catalog Number:
25316-40-9
Synonyms:
Adriamycin
CAS Number:
25316-40-9
Description:
Doxorubicin (Adriamycin) is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis.
Molecular Weight:
579.98
Molecular Formula:
C27H30ClNO11
COA:
Inquire
MSDS:
Inquire
Tag:
ADCs Cytotoxin
Chemical Structure
CAS 25316-40-9 Doxorubicin hydrochloride

Related ADCs Cytotoxin Products


CAS 22273-09-2 Vincanidine HCl

Vincanidine HCl
(CAS: 22273-09-2)

Extractedfrom Vinca erecta. A dopamine receptor stimulating agent Indolinine alkaloid

CAS 22352-41-6 Hippeastrine hydrobromide

Hippeastrine hydrobromide
(CAS: 22352-41-6)

Amaryllidaceae alkaloid from plants of the Amaryllidaceae family. A hypotensive, sedative. Amaryllidaceae alkaloid , from plants of the Amaryllidaceae family.

CAS 228266-41-9 Taltobulin trifluoroacetate

Taltobulin trifluoroacetate
(CAS: 228266-41-9)

Taltobulin trifluoroacetate (HTI-286; SPA-110) is an analogue of Hemiasterlin; potent tubulin inhibitor; ADCs cytotoxin.

CAS 202350-68-3 PNU-159682

PNU-159682
(CAS: 202350-68-3)

PNU-159682 is a major active metabolite of nemorubicin (MMDX) in human liver microsomes. PNU-159682 showed > 3,000-fold cytotoxic than its parent compound(MMDX ...

alpha-Short neurotoxin

α-Neurotoxins from snake venoms that tightly bind nAChRs contain 60-75 amino acid (aa) residues and are linked by 4-5 disulfide bridges. an antagonist of the ni...

CAS 21314-60-3 Pentazolone hydrochloride

Pentazolone hydrochloride
(CAS: 21314-60-3)

Synthetic, an inhibitor of monoamine oxydase.Enhances the toxicity of the Phenamine group and of Tryptamine.

CAS 67526-95-8 Thapsigargin

Thapsigargin
(CAS: 67526-95-8)

Potent, cell-permeable, IP3-independent intracellular calcium releaser. Blocks the transient increase in intracellular Ca2+ induced by angiostatin and endostati...

FSP-3

Anticoagulant: irreversible inhibits serine proteinase a-thrombine. Fluorocontaining phosphonate, synthetised.

CAS 66547-09-9 Ansamitocin P-3

Ansamitocin P-3
(CAS: 66547-09-9)

Ansamitocin P-3, a potent anti-tumor maytansinoid found in Actinosynnema pretiosum, is a maytansine analog which displays potent cytotoxicity against the human ...

CAS 290304-24-4 Daun02

Daun02
(CAS: 290304-24-4)

Daun02 is a daunorubicin b-galactoside prodrug for use in conjunction.

CAS 4368-28-9 Tetrodotoxin

Tetrodotoxin
(CAS: 4368-28-9)

TTX is a potent marine-derived neurotoxin that reversibly inhibits the inward sodium current through voltage-activated sodium (NaV) channels, blocking nerve and...

CAS 6659-51-4 Quireston

Quireston
(CAS: 6659-51-4)

Synthetic, a potent inhibitor of high-affinity choline uptake (HAChU) in synaptosomes.

CAS 51424-33-0 alpha-Salsoline HCl

alpha-Salsoline HCl
(CAS: 51424-33-0)

Alkaloid, Tetrahydroisoquinoline, Active dopamine metabolite, Cholinesterase inhibitor

CAS 23541-50-6 Daunorubicin Hydrochloride

Daunorubicin Hydrochloride
(CAS: 23541-50-6)

Daunorubicin Hcl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM.

CAS 224790-70-9 Cloflubicyne

Cloflubicyne
(CAS: 224790-70-9)

Cloflubicyne is a potent non-competitive GABA antagonist, convulsant, laboratory insecticide.

CAS 39380-16-0 Tschimganidine

Tschimganidine
(CAS: 39380-16-0)

Terpenoids found in the umbelliferae family act as agonists/antagonists for ER(alpha) and Erbeta.

Maurocalcin

Synthetic, from Scorpio maurus palmatus scorpion venom. An activator of Ca2+ release channel/ryanodine receptors. 33-mer basic peptide cross-linked by three dis...

LK-66 M

A muscarinic receptors antagonist.

CAS 17669-16-8 Remerine HCl

Remerine HCl
(CAS: 17669-16-8)

Aporphine alkaloid , from plants of the Papaveraceae family, a CNS stimulant which enhances the analeptic effects of caffeine and strychnine.

CAS 4838-99-7 Unsevine

Unsevine
(CAS: 4838-99-7)

Unsevine acts directly on the CNS, inhibits the reaction of orientation, prolongs the action of soporifics, enhances the effects of analgesics and prevents conv...

Reference Reading


1.Electrochemical Behavior and Square Wave Voltammetric Determination of Doxorubicin Hydrochloride
Younghee Hahn and Ho Young Lee. Arch Pharm Res Vol 27, No 1, 31-34, 2004
The detecting system connected to CE was a carbon disk working electrode with an applied potential of 0.95 V vs. a Ag/AgCI (3 M KCI), which measured anodic currents due to the oxidation of two phenolic hydroxyls in the aglycone of daunorubicin (Hu et aL, 2000). Meanwhile, reductive detecting system measured at -0.30 V was preferred to oxidation in which the chromatographic profile suffered severe interference from substances that result from the biological matrix (Ricciarello et aL, 1998). Electrochemical assay often offers selectivity and sensitivity due to the selective detection of electroactive species among the complex samples. The chemical structure of doxorubicin contains a electrochemically a reducible quinone moiety in the aglycone which prompted us to study its electro-chemical behavior by using mercury electrodes, followed by developing the fast and sensitive square wave voltammetric (SWV) procedure for the determination of doxorubicin hydrochloride in the present study.
2.Facile fabrication of thermally responsive Pluronic F127-based nanocapsules for controlled release of doxorubicin hydrochloride
Zhipeng Zeng & Zhiping Peng & Lei Chen & Yiwang Chen. Colloid Polym Sci (2014) 292:1521–1530
The short cross-linking reaction time led to the formation of nanocapsules with thin and low-cross-linked PL shell because the cross-linking reaction between the –NPC groups and –NH2 groups was slow. The difference of the contrast between the PL shell and the hollow core resulted in the typical empty core–shell structure which can be found in the TEM images. After reacting for 20 h, the diameter of the nanocapsules increased to about 200 nm as shown in Fig. 2b. Assuming that the size change of the inner cavity was negligible, the thickness of the PL shell can be estimated to be more than 60 nm. The denser and tighter (with high cross-linking density for long reaction time) PL shell resulted in the empty core–shell structure invisible in the TEM image even though the hollow inner cavity was still there. For the Pluronic F127/HA nanocapsules as shown in Fig. 2d, the smaller and instable nanocapsules were formed because of the slower reaction rate between –COOH groups and –NH2 groups. After reacting for 20 h, the diameter of the Pluronic F127/HA nanocapsules was determined to be about 220 nm. The size of the Pluronic F127/HA nanocapsules was larger than the Pluronic F127/PL nanocapsules because the content of HA was more than PL taken up by the nanocapsules. The average size was consistent with those determined from DLS results.
3.A Method for Evaluation of Therapeutic Dose of Doxorubicin Hydrochloride Using Breast Tumor Cell Culture MCF-7
Ya. D. Shanskij, Yu. A. Ershov*, and V. M. Pechennikov*. Bulletin of Experimental Biology and Medicine, Vol. 148, No. 3, 2009
Statistical data suggest that the use of anticancer drug does not signifi cantly increase the total survival of patient. This is largely associated with difficulties in rational regimen of drug usage. The choice of the dose of anticancer drugs is mainly empirical. This is also true for doxorubicin hydrochloride, antitumor antibiotic of the anthracycline family used for breast cancer management.